Vistas y estadísticas descargadas: Expert Consensus on the Management of Adverse Events of Lorlatinib in the Treatment of ALK+ Advanced Non-small Cell Lung Cancer
Mapa geográfico
| Región | # |
|---|---|
| NA - América del Norte | 37 |
| EU - Europa | 36 |
| AS - Asia, otros | 26 |
| SA - América del Sur | 1 |
| Desconocido | 3 |
| Total | 103 |
| País | # |
|---|---|
| US - Estados Unidos de América | 37 |
| BG - Bulgaria | 16 |
| CN - China | 14 |
| SG - Singapur | 11 |
| ES - España | 8 |
| DE - Alemania | 5 |
| IE - Irlanda | 3 |
| RU - Federación Rusa | 3 |
| BR - Brasil | 1 |
| GB - Reino Unido | 1 |
| other - Otro País | 4 |
| Total | 103 |
| Ciudad | Cantidad |
|---|---|
| Sofia | 16 |
| Singapore | 8 |
| Frankfurt am Main | 4 |
| Hangzhou | 4 |
| Beijing | 3 |
| Clonee | 3 |
| Ashburn | 2 |
| Chuzhou | 2 |
| Dongguan | 2 |
| Atlanta | 1 |
| other | 58 |
| Total | 103 |
| Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Tot | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 54 | 10 | 15 | 5 | 4 | 88 |
| 2025 | 2 | 5 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| TOTAL | 103 | ||||||||||||